Failure of Host Defenses in Human Immunodeficiency Virus

Seminars in Respiratory and Critical Care Medicine

Volumn 25, Issue 1, 2004, Pages 73-84

  Shellito, Judd E ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alveolar macrophages; CD4+ T lymphocytes; CD8+ T lymphocytes; Chemokines; Collectins; Cytokines; Defensins; Dendritic cells; Host defense against infection; Immunoglobulins; Mucociliary function; Natural killer cells; Neutrophils

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; COLLECTIN; CYTOKINE; DEFENSIN; IMMUNOGLOBULIN;

BACTERIAL PNEUMONIA; CANDIDIASIS; CELL MIGRATION; CELLULAR IMMUNITY; CILIATED EPITHELIUM; DENDRITIC CELL; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION SENSITIVITY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; LYMPHOCYTE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECI; PRIORITY JOURNAL; REVIEW; SECRETION; T LYMPHOCYTE;

EID: 1542363538     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-822307     Document Type: Review

References (102)

1. Davis L, Beck J, Shellito J. Update: HIV infection and pulmonary host defenses. Semin Respir Infect 1993;8:75-85
2. Crowe S, Carlin JKS, Lucas C, Hoy J. Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons. J Acquir Immune Defic Syndr 1991;4:770-776
3. Agostini C, Zambello R, Trentin L, Semenzato G. HIV and pulmonary immune responses. Immunol Today 1996;17:359-364
4. Twigg H, Soliman D, Day R, et al. Lymphocytic alveolitis, bronchoalveolar lavage, viral load, and outcome in human immunodeficiency virus infection. Am J Respir Crit Care Med 1999;159:1439-1444
5. Wahl S, Orenstein J. Immune stimulation and HIV-1 viral replication. J Leukoc Biol 1997;62:67-71
6. Whalen C, Horsburgh C, Hom D, Lahart C, Simberkoff M, Ellner J. Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-135
7. Milgrim LM, Rubin JS, Small CB. Mucociliary clearance abnormalities in the HIV-infected patient: a precursor to acute sinusitis [see comment]. Laryngoscope 1995;105:1202-1208
8. + count using IgA and clinical signs in HIV-seropositive i.v. drug users. Infection 1997;25:117-120
9. Fong I, Laurel M, Burford-Mason A. Asymptomatic oral carriage of Candida albicans in patients with HIV infection. Clin Invest Med 1997;20:85-93
10. Slavinsky J III, Myers T, Swoboda RK, Leigh JE, Hager S, Fidel PL Jr. Th1/Th2 cytokine profiles in saliva of HIV-positive smokers with oropharyngeal candidiasis. Oral Microbiol Immunol 2002;17:38-43
11. Lin A, Johnson D, Patterson T, et al. Salivary anticandidal activity and saliva composition in an HIV-infected cohort. Oral Microbiol Immunol 2001;15:270-278
12. Sweet S, Cookson S, Challacombe S. Candida albicans isolates from HIV-infected and AIDS patients exhibit enhanced adherence to epithelial cells. J Med Microbiol 1995;43:452-457
13. Ollert M, Wende C, Gorlich M, et al. Increased expression of Candida albicans secretory proteinase, a putative virulence factor, in isolates from human immunodeficiency virus-positive patients. J Clin Microbiol 1995;33:2543-2549
14. Wallace J, Hansen N, Lavange L, et al. Respiratory disease trends in the Pulmonary Complications of HIV Infection Study Cohort. Am J Respir Crit Care Med 1997;155:72-80
15. Verghese A, al-Samman M, Nabhan D, Naylor A, Rivera M. Bacterial bronchitis and bronchiectasis in human immunodeficiency virus infection. Arch Intern Med 1994;154:2086-2091
16. Tsang C, Samaranayake L. Salivary lysozyme and related parameters of a predominantly Chinese, HIV-infected cohort in Hong Kong. Oral Dis 1999;5:241-246
17. Mandell I, Barr C, Turgeion L. Longitudinal study of parotid saliva in HIV-1 infection. J Oral Pathol Med 1992;21:209-213
18. Muller F, Holberg-Petersen M, Rollag H, Degre M, Brandtzaeg P, Froland S. Nonspecific oral immunity in individuals with HIV infection. J Acquir Immune Defic Syndr 1992;5:46-51
19. Zhang L, Yu W, He T, et al. Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 2002;298:995-1000
20. Martin WN, Downing J, Williams M, Pasula R, Twigg H, Wright J. Role of sufactant protein A in the pathogenesis of tuberculosis in subjects with human immunodeficiency virus infection. Proc Assoc Am Physicians 1995;107:340-345
21. Garred P, Madsen H, Balslev U, et al. Susceptibility to HIV infection and progression of AIDS in relation to vairent alleles of mannose-binding lectin. Lancet 1997;349:236-240
22. Margalith M, Levy E, Rinaldo C, et al. HIV-1 IgA specific serum antibodies and disease progression during HVI-1 infection. J Hum Virol 2001;4:269-277
23. Cartry O, Moja P, Quesnel A, Pozzetto B, Lucht F, Genin C. Quantification of IgA and IgG and specificities of antibodies to viral proteins in parotid saliva at different stages of HIV-1 infection. Clin Exp Immunol 1997;109:47-53
24. Wu X, Jackson S. Plasma and salivary IgA subclasses and IgM in HIV-1-infected individuals. J Clin Immunol 2002;22:106-115
25. Agostini C, Zambello R, Trentin L, et al. Prognositc significance of the evaluataion of bronchoalveolar lavage populations in patients with HIV-infection and pulmonary involvement. Chest 1991;100:1601-1606
26. Agostini C, Trentin L, Zambello R, et al. Release of GM-CSF by alveolar macrophages in the lung of HIV-1 infected patients: a mechanism accounting for macrophage and neutrophil accumulation. J Immunol 1992;149:3379-3385
27. Murray H, Gellen R, Libby D, Rothermel C, Rubin B. Activation of tissue macrophages from AIDS patients: in vitro responses of AIDS alveolar macrophages to lymphokines and gamma interferon. J Immunol 1985;135:2374-2379
28. Gordon S, Molyneux M, Boeree M, et al. Opsonic phagocytosis of Streptococcus pneumoniae by alveolar macrophages is not impaired in human immunodeficiency virus-infected Malawian adults. J Infect Dis 2001;184:1345-1349
29. Musher D, Watson D, Nickeson D, Gyorkey F, Lahart C, Rossen R. The effect of HIV infection on phagocytosis and killing of Staphylococcus aureus by human pulmonary alveolar macrophages. Am J Med Sci 1990;299:158-163
30. Lipman M, Johnson J, Poulter L. Functionally relevant changes in occur in HIV-infected individuals' alveola macrophages prior to the onset of respiratory disease. AIDS 1997;11:765-772
31. Koziel H, Li X, Armstron M, Richards F, Rose R. Alveolar macrophages from human immunodeficiency virus-infected persons demonstrate impaired oxidative burst response to Pneumocystis carinii in vitro. Am J Respir Cell Mol Biol 2000;23:452-459
32. Chaturvedi S, Frame P, Newman S. Macrophages from human immunodeficiency virus-positive persons are defective in host defense against Histoplasma capsulatum. J Infect Dis 1995;171:320-327
33. Cameron M, Granger D, Matthews T, Weinberg J. Human immunodeficiency virus (HIV)-infected human blood monocytes and peritoneal macrophages have reduced anticryptococcal activity whereas HIV-infected alveolar macrophages retain normal activity. J Infect Dis 1994;170:60-67
34. Leong M, Reardon C, Levitz S, Kornfeld H. Human immunodeficiency virus type 1 infection of alveolar macrophages impairs their innate fungicidal activity. Am J Respir Crit Care Med 2000;162:966-970
35. Agostini C, Trentin L, Zambello R, Semenzato G. HIV-1 and the lung: infectivity, pathogenic mechanisms, and cellular immune responses taking place in the lower respiratory tract. Am Rev Respir Dis 1993;147:1038-1049
36. Orenstein J, Fox C, Wahl S. Macrophages as a source of HIV during opportunistic infections. Science 1997;276:1857-1861
37. Lebargy F, Branellec A, Deforges L, Bignon J, Bernaudin J. HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation. Am J Respir Cell Mol Biol 1994;10:72-78
38. Plata F, Autran B, Martins LP, et al. AIDS virus-specific cytotoxic T lymphocytes in lung disorders. Nature 1987;328:348-351
39. Autran B, Mayaud C, Raphael M, et al. Evidence for a cytotoxic T lymphocyte alveolitis in human immunodeficiency virus-infected patients. AIDS 1988;2:179-183
40. Chayt K, Harper M, Marselle L, et al. Detection of HTLV-III RNA in lungs of patients with AIDS and pulmonary involvement. JAMA 1986;256:2356-2359
41. Lewin S, Krihara J, Sonza S, Irving I, Mills J, Crowe S. HIV-1 DNA and mRNA concentrations are similar in peripheral blood monocytes and alveolar macrophages in HIV-1-infected individuals. AIDS 1998;12:719-727
42. Herbein G, Coaquette A, Perez-Bercoff D, Pancino G. Macrophage activation and HIV infection: can the Trojan horse turn into a fortress? Curr Mol Med 2002;2:723-738
43. Gordon S, Read R. Macrophage defences against respiratory tract infections. Br Med Bull 2002;61:45-61
44. Sewell A, Price D. Dendritic cells and transmission of HIV. Trends Immunol 2001;22:173-175
45. Macatonia S, Lau R, Patterson S, Pinching A, Knight S. Dendritic cell infection, depletion, and dysfunction in HIV-infected individuals. Immunology 1990;71:38-45
46. Mason G, Hasimota C, Dickman P, Foutty L, Cobb C. Prognostic implications of bronchoalvelar lavage neutrophilia in patients with Pneumocystis carinii pneumonia and AIDS. Am Rev Respir Dis 1989;139:1336-1342
47. Ellis M, Gupta S, Galant S, et al. Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation. J Infect Dis 1988;158:1268-1276
48. Roilides E, Walsh T, Pizzo P, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991;163:579-583
49. Murphy P, Lane H, Fauci A, Gallin J. Impairment of neutrophil bactericidal capacity in patients with AIDS. J Infect Dis 1988;158:627-630
50. Monari C, Casadevall A, Pietrella D, Bistoni F, Vecchiarelli A. Neutrophils from patients with advanced human immunodeficiency virus infection have impaired complement receptor function and preserved Fc gamma receptor function. J Infect Dis 1999;180:1542-1549
51. Gasperini S, Zambello R, Agostini C, et al. Impaired cytokine production by neutrophils isolated from patients with AIDS. AIDS 1998;12:373-379
52. Coffey M, Phare S, George S, Peters-Golden M, Kazanjian P. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. J Clin Invest 1998;102:663-670
53. Mastroianni C, Lichtner M, Mengoni F, et al. Improvement in neutrophil and monocyte function during highly active antiretroviral treatment of HIV-1-infected patients. AIDS 1999;13:883-890
54. Sandberg J, Fast N, Palacios E, et al. Selective loss of innate CD4(+) V alpha 24 natural killer T cells in human immunodeficiency virus infection. J Virol 2002;76:7528-7534
55. Bruunsgaard H, Pedersen C, Skinhoj P, Pedersen B. Clinical progression of HIV infection: role of NK cells. Scand J Immunol 1997;46:91-95
56. Fehniger T, Herbein G, Yu H, et al. Natural killer cells from HIV-1+ patients produced C-C chemokines and inhibit HIV-1 infection. J Immunol 1998;161:6433-6438
57. Israel-Biet D, Cadranel J, Beldjord K, Andrieu J, Jeffrey A, Even P. Tumor necrosis factor production in HIV-seropositive subjects: relationship with lung opportunistic infections and HIV expression in alveolar macrophages. J Immunol 1991;147:490-494
58. Trentin L, Garbisa S, Zambello R, et al. Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type 1-infected patients. J Infect Dis 1992;166:731-737
59. Lipschik G, Doerfler M, Kovacs J, et al. Leukotriene B4 and interleukin-8 in human immunodeficiency virus-related pulmonary disease. Chest 1993;104:763-769
60. Wewers M, Diaz P, Wewers M, Lowe M, Nagaraja H, Clanton T. Cigarette smoking in HIV infection induces a suppressive inflammatory environment in the lung. Am J Respir Crit Care Med 1998;158:1543-1549
61. Guillon M, Autran B, Denis M, et al. Human immunodeficiency virus related lymphocytic alveolitis. Chest 1988;94:1264-1270
62. Agostini C, Zambello R, Trentin L, et al. Cytototoxic events taking place in the lung of patients with HIV infection: evidence for an intrinsic defect of the MHC-unrestricted killing partially restored by the incubation with rIL-2. Am Rev Respir Dis 1990;142:516-522
63. + lymphocytes in human immunodeficiency virus infection produce an inhibitor of cytotoxic functions. Am J Respir Crit Care Med 1994;149:972-980
64. Twigg H, Spain B, Soliman D, et al. Production of interferon-gamma by lung lymphocytes in HIV-infected individuals. Am J Physiol 1999;276:L256-L262
65. + T cells in the lungs of patients with HIV infection and T-cell alveolitis. Am J Respir Crit Care Med 2000;162:1466-1473
66. Spain B, Soliman D, Sidner R, Twigg H. Enhanced proliferation and IL-2 secretion by lung lymphocytes from HIV-infected subjects. Am J Physiol 1995;269:L498-L506
67. Autran B, Plata F, Guillon J, Joly P, Mayaud C, Debre P. HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-1 infected patients. Res Virol 1990;141:131-136
68. Augustin A, Kubo R, Sim G. Resident pulmonary lymphocytes expressing the gamm/delta T-cell receptor. Nature 1989;340:239-241
69. Kaufmann S. Gamma/delta and other unconventional lymphocytes: what do they see and what do they do? Proc Natl Acad Sci USA 1996;93:2272-2279
70. Poccia F, Battistini L, Cipriani B, et al. Phosphoantigen-reactive Vdelta9Vdelta2 T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J Infect Dis 1999;180:858-861
71. Malkovsky M, Wallace M, Fournie J, Fisch P, Poccia F, Gougeon M. Alternative cytotoxic effector mechanisms in infections with immunodeficiency viruses: gamm delta T lymphocytes and natural killer cells. AIDS 2000;14(suppl 3): S175-S186
72. Twigg H, Blake A, Soliman D, Bowen L, Heidler K, Wilkes D. Impaired IgG production in the lungs of HIV-infected individuals. Cell Immunol 1996;170:127-133
73. Fahy R, Diaz P, Hart J, Wewers M. BAL and serum IgG levels in healthy asymptomatic HIV-infected patients. Chest 2001;119:196-203
74. Wallace J, Rao V, Glassroth J, et al. Respiratory illness in persons with human immunodeficiency virus infection. Am Rev Respir Dis 1993;148:1523-1529
75. Hirschtick R, Glassroth J, Jordan M, et al. Bacterial pneumonia in patients with HIV infection: pulmonary complications of HIV infection study group. N Engl J Med 1995;333:845-851
76. Moore R, Keruly J, Chaisson R. Neutropenia and bacterial infection in acquired immunodeficiency syndrome. Arch Intern Med 1995;155:1965-1970
77. Hundt M, Heiken H, Schmidt R. Association of low mannose-binding lectin serum concentrations and bacterial pneumonia in HIV infection. AIDS 2000;14:1853-1876
78. Keller D, Breiman R. Preventing bacterial respiratory tract infections among persons infected with human immunodeficiency virus. Clin Infect Dis 1995;21(suppl 1):S77-S83
79. Kielhofner M, Atmar R, Hamil R, Musher D. Life-threatening Pseudomonas aeruginosa infections in patients wiht human immunodeficiency virus infection. Clin Infect Dis 1992;14:403-411
80. Mitchell D, Miller F. New developments in the pulmonary diseases affecting HIV-infected patients. Thorax 1995;50:294-302
81. Verville TD, Huycke MM, Greenfield RA, Fine DP, Kuhls TL, Slater LN. Rhodococcus equi infections of humans. 12 cases and a review of the literature. Medicine 1994;73:119-132
82. Uttamchandani R, Daikos G, Reyes R, et al. Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin Infect Dis 1994;18:348-353
83. Magnenat J, Nicod L, Auckenthaler R, Junod A. Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus-infected patients. Am Rev Respir Dis 1991;144:917-922
84. Gil Suay V, Cordero P, Martinez E, et al. Parapneumonic effusions secondary to community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients. Eur Respir J 1995;8:1934-1939
85. Plouffe J, Breiman R, Facklam R. Bacteremia with Streptococcus pneumoniae. JAMA 1996;275:194-198
86. Miller RF, Foley NM, Kessel D, Jeffrey AA. Community acquired lobar pneumonia in patients with HIV infection and AIDS. Thorax 1994;49:367-368
87. Gilks C, Ojoo S, Ojoo J, et al. Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya. Lancet 1996;347:718-723
88. Osmond D, Chin D, Glassroth J, et al. Impact of bacterial pneumonia and Pneumocystis carinii pneumonia on human immunodeficiency virus disease progression. Pulmonary Complications of HIV Study Group. Clin Infect Dis 1999;29:536-543
89. Maynaud C, Parrot A, Cadranel J. Pyogenic bacterial lower respiratory tract infection in human immunodeficiency virus-infected patients. Eur Respir J 2002;36:S28-S39
90. Masur H, Ognibene F, Yarchoan R, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency (HIV) infection. Ann Intern Med 1989;111:223-231
91. CDC. Guidelines for prophylaxis against Pneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR Morb Mortal Wkly Rep 1989;38(suppl S-5):1-9
92. Stansell JD, Osmond DH, Charlebois E, et al. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary complications of HIV infection study group. Am J Respir Crit Care Med 1997;155:60-66
93. Glatt A, Chirgwin K. Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Arch Intern Med 1990;150:271-279
94. Ewig S, Bauer T, Schneider C, et al. Clinical characteristics and outcome of Pneumocystis carinii pneumonia in HIV-infected and otherwise immunosuppressed patients. Eur Respir J 1995;8:1548-1553
95. Limper A, Offord K, Smith T, Martin WI. Pneumocystis carinii pneumonia: differences in lung parasite number and inflammation in patients with and without AIDS. Am Rev Respir Dis 1989;140:1204-1209
96. White D, Gellene R, Gupta S, Cunningham-Rundles C, Stover D. Pulmonary cell populations in the immunosuppressed patient: bronchoalveolar lavage findings during episodes of pneumonitis. Chest 1985;88:352-359
97. Smith RL, el-Sadr WM, Lewis ML. Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia. Chest 1988;93:60-64
98. + T-lymphocytes subsets and host defense against Pneumocystis carinii. J Infect Dis 2000;181:2011-2017
99. Hahn P, Limper A. The role of inflammation in respiratory impairment during Pneumocystis carinii pneumonia. Semin Respir Infect 2003;18:40-47
100. Benfeld TL, Helweg-Larsen J, Bang D, Junge J, Lundgren JD. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia. Chest 2001;119:844-851
101. The National Institutes of Health-University of California Expert Panel. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;323:1500-1504
102. Ruan S, Tate C, Lee J, Ritter T, Kolls J, Shellito J. Local delivery of the viral interleukin-10 gene suppresses tissue inflammation in murine Pneumocystis carinii infection. Infect Immun 2002;70:6107-6113